NAMA
ADPT icon

Nikko Asset Management Americas’s Adaptive Biotechnologies ADPT Stock Holding History

Nikko Asset Management Americas’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.5M Sell
1,329,856
-265,514
-17% -$4.07M 0.37% 59
2026
Q1 		$22.1M Sell
1,595,370
-352,593
-18% -$5.62M 0.31% 61
2025
Q4 		$31.6M Sell
1,947,963
-1,702,683
-47% -$27.8M 0.37% 58
2025
Q3 		$54.7M Sell
3,650,646
-649,038
-15% -$7.91M 0.53% 47
2025
Q2 		$50M Sell
4,299,684
-1,786,006
-29% -$16.2M 0.5% 46
2025
Q1 		$45.2M Sell
6,085,690
-747,447
-11% -$5.74M 0.58% 44
2024
Q4 		$40.9M Sell
6,833,137
-900,747
-12% -$4.97M 0.44% 49
2024
Q3 		$39.5M Buy
7,733,884
+814,106
+12% +$3.55M 0.45% 50
2024
Q2 		$25M Buy
6,919,778
+743,071
+12% +$2.36M 0.29% 60
2024
Q1 		$19.8M Sell
6,176,707
-334,952
-5% -$1.3M 0.2% 69
2023
Q4 		$31.9M Sell
6,511,659
-59,280
-0.9% -$270K 0.31% 57
2023
Q3 		$35.7M Buy
6,570,939
+186,892
+3% +$1.24M 0.43% 50
2023
Q2 		$42.8M Buy
6,384,047
+1,061,511
+20% +$7.89M 0.45% 46
2023
Q1 		$44.7M Sell
5,322,536
-29,779
-0.6% -$263K 0.51% 38
2022
Q4 		$40.7M Buy
5,352,315
+514,124
+11% +$4M 0.59% 37
2022
Q3 		$33.2M Buy
4,838,191
+219,792
+5% +$2.07M 0.42% 47
2022
Q2 		$36.1M Buy
4,618,399
+477,621
+12% +$4.2M 0.45% 48
2022
Q1 		$56.5M Buy
4,140,778
+979,855
+31% +$15.4M 0.42% 46
2021
Q4 		$87.1M Buy
3,160,923
+1,133,445
+56% +$34.7M 0.46% 44
2021
Q3 		$66.8M Buy
2,027,478
+245,259
+14% +$8.87M 0.29% 67
2021
Q2 		$71.3M Buy
1,782,219
+1,383,409
+347% +$53.8M 0.28% 68
2021
Q1 		$16.1M Buy
398,810
+173,991
+77% +$9.42M 0.08% 115
2020
Q4 		$13.3M Buy
224,819
+34,356
+18% +$1.77M 0.08% 120
2020
Q3 		$7.81M Buy
190,463
+23,890
+14% +$1M 0.07% 122
2020
Q2 		$7.04M Buy
+166,573
New +$6.07M 0.09% 94

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Nikko Asset Management Americas's ADPT Position: Q2 2026 in Review

Nikko Asset Management Americas reduced its Adaptive Biotechnologies (ADPT) stake by 17% in Q2 2026, selling an estimated $4.07M and leaving 1,329,856 shares worth $28.5M. The position accounts for 0.37% of the portfolio, ranked #59.

Nikko Asset Management Americas first reported a position in ADPT in Q2 2020 and has held it in 25 quarters since. The position peaked at $87.1M in Q4 2021. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Nikko Asset Management Americas held 1,329,856 shares of Adaptive Biotechnologies worth $28.5M as of Q2 2026.
  • Nikko Asset Management Americas sold 265,514 Adaptive Biotechnologies shares in Q2 2026, an estimated $4.07M.
  • Adaptive Biotechnologies made up 0.37% of Nikko Asset Management Americas's portfolio in Q2 2026, its #59 holding.
  • Nikko Asset Management Americas first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 25 quarters since.
  • Nikko Asset Management Americas's Adaptive Biotechnologies position peaked at $87.1M in Q4 2021.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Nikko Asset Management Americas's 13F filing for Q2 2026, filed 13 Aug 2026.